A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants

The emergence of antigenically distinct severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increased transmissibility is a public health threat. Some of these variants show substantial resistance to neutralization by SARS-CoV-2 infection- or vaccination-induced antibodies, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitz, Aaron J., Turner, Jackson S., Liu, Zhuoming, Aziati, Ishmael D., Chen, Rita E., Joshi, Astha, Bricker, Traci L., Darling, Tamarand L., Adelsberg, Daniel C., Alsoussi, Wafaa B., Case, James Brett, Lei, Tingting, Thapa, Mahima, Amanat, Fatima, O’Halloran, Jane A., Shi, Pei-Yong, Presti, Rachel M., Krammer, Florian, Bajic, Goran, Whelan, Sean P.J., Diamond, Michael S., Boon, Adrianus C. M., Ellebedy, Ali H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010723/
https://www.ncbi.nlm.nih.gov/pubmed/33791696
http://dx.doi.org/10.1101/2021.03.24.436864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010723/
https://www.ncbi.nlm.nih.gov/pubmed/33791696
http://dx.doi.org/10.1101/2021.03.24.436864

Ejemplares similares